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A traditional concept of pure nitrogenous bubble embolixation li:As
arisen as the etiologic factor in decompression sickness. Quite properly
recompression has been employed as the means of treating this syndrome.
The resu l ts of treatment were usually dramatic ' 6nd effective.
In 1961, we emphasized the importance of hcmoconcentration in
altitude type bends cases and suggested the extent of the plasma deficit
based on standard clinical data. 1 Subsequent studies by our group employing
mongrel cloys previously splenc-itemized documented' the exiont -of this plash.
	 U
loss 2. 	Dextran (LIMI) replucement was effective in treating shock and
maintaining an effective circulating blood volume. 3,4 Recompression was
deliberately withheld:
Th-j.,se early findings suggested to us thot ili a. syndroma of decompression
sickness was more complex than the simple bubble theory. LVY/ dextran
reverses blood viscosity caused by fibrinogen by fern*.. `ion of a dextran-
fibrinogen, complex, This role is in addition to its colloidal, expansive
properties. DNV,tran also affects hemostasis; it apparently alters the red
blood cell surface by increasin;,j its negativity thus encouraging repulsion
of red blood cells.
A chance finding subsequently reported by our group s,:omed to
clarify our un rl<^rsiandinu of this syndrome. We reported bone marrow emboli
in pulmonary arterioles following experim--nial decompression sickness, 5 and
sucggesicd?
 1 1ruct a num6ar of conix,li in lice lungs; kidney urid liver wcro of a
w 2 «
lipid nature. This new wide based approach was amply supporied by our
results in treating h nrins with ckncompression sickness. Dextran infusion
begun immcdicaely of ar diaE)nosis improved the patients ShOCiail;e ;late
and shortened the recompression schedule.
Recently we have re-sectioned -lung areas known to be involved
by emboli following ex; -arimental decompression. These pulmonary areas
were obtained by biopsy or postmortem examination. Pulmonary localiza-
tion in 14 dogs wos made possible after the development and refinerscnt
of radioisotopic pulmonary scanniny.techniquiCs.6
The purpose of this study is to report the results of tissue sectioning
of lungs in animals overcomprossed to 165 feet, maintained at depth for
60 minutes, and then docompressod to surface. Oil•-red••0 stains were made
of treated and untreated animals. Treatment consisted of Lh%' dextran or y.
intravenous heparin.
MATERIALS AND METHODS
Thirty-three mongrel dogs vrere , employed in this study. All animals
were overcompressod to 165 feet V3.5 PSIG) for 60 minutes. We have
previously described our protoc,-,l. 	 '
Five animals unexposed to the chamber were sacrificed to provide
baseline glair, 'or routine pulmonary fat stains.
.. 3 ...
Fourteen animals were treated by dextran following decompression.
These anirnals undorvrent lug o biopsy /B hours after the chamber procedure
.and immadicifoly following a second lung scan.
A third group of M aniMUIS was ovorcompressed in the usual fashion.
After chamber removal five animals served as exposed but untreated ecoirols
while ten animals received IV heparin 3 hours after chamber removal.
The control animals expired. Fat stains were made of lung tissue. Biopsies
provided the basis for fat stains in the heparin treated group.
RESULTS
Unexposr:.d Control Animals (5 clogs)
Fat globules may be seen occossionally in lungs of animals previously
fasted for 24 hours. The fat globules are di-fficult • .to locate and may be seen
in areas containing the smaller blood vessels near the bronchial cartilages.
Exposed Untreated Animals (5 clogs)
Numerous lipid einboli are easily seen on routine sections (Figures 1
and 21. The emboli appear most frequently in areas where hemorrhage and
pulmonary edema are present.
Exposed and Treater! Animals_ (24 dogs),
Fourteen clogs were treated, by dextran alone.
	 Ten animals were
r d r
treated by hopvrin alone (fable 1). F:y idcnce of hemorrhage and pulmoncry
edema existing in pulmonary areas diagnosed by radioisotopic lung scanning
is seen (Figure 3). Fat emboli are also &oen in biopsied areas 48 hours
after decompress ion (Figure /).	 1
'DISCUSSION
Philp ct•al 7 and Partholomy have reported the benefits of heparin
as a lipemie Oearing agent in decompression sickness. . Survival rates wcrc
significantly improved Mill heparin. We recently confirmed the benefits of
9heparin in experimental decompression sickness lipid erabolization would
appear to be significant since recompression was not employed, and heparin
was Protect-h .
While gaseous embolization is undoubtedly a major factor in the
genesis of decompression sickness, our experience with dextran would suggest
the more imporiont role of lipid emboli. lipid content is also reduced
after dextran treattn:.nt. A resemblance exists bolween truurnatic .fatty
emboli ation and decompression sickness. Striking similarities when comparing
both clinical syndromes are as follows:
1) A latent period develops before the onset of syrniitoms.
2)	 Symptomatology are identical in both. They include puhronary
edema, hypoxia, shod: and central nervous systern signs.
J) Pelechiae in patients with decompression sickness tollo,v skin
patterns described in fat ambolisrn.
4) IllheropcM is ren imens are similar.
SUMMARY AND CONCLUSIONS
1) Lipid ombolization would appear to play a molar role in flip.
genesis of doe omp ression sickness.
2) Evidence for the co-existence of lipid emboli c;nd gm'-- us
emboli is presented.
3) Heparin or dextran-effective lipemic clearing agents—arc
.	 beneficial in treating experimental decompression sickness.
4) A .combined therapeutic approach—recompression and dextran
should be employed in treating human decompression sickness. Heparin
may serve as u substitute in selected instances,
LEGENDS
Figure 1.	 Photornicrororap!i d-clonstrating fat emboli in small capillaries
in pulmonary region (101OX)
Figure 2. Fat erutiolus (oil-red-0) in capillary in lung (125X.)
.	 Figure 3. flernorrhage and pulmoncn •y edema in Ivng of dog orposed
to 165 feet for 60 minutes (60X)
Figure 4. Fat emboli (oil-red-0) in small vessels surrounding
bronchioles (`00X)
4.
L.
to
,.
- REFERENCES
2.
3.
5.
6.
7.
Watts-, W.G., J.B. Fitzgerald and A.T.K. Cockott: Dysbarism: A
P.oviow with Suclqesllons for Therapy. Aerospace Med. 33:1132, 1962.
Cockott, A.T.IC., R.M. Nakamura and JJ. Franks: Delayed Shock
in Experimental Dysbarism. Surg. Forum 14:7, 1963.
Cockett, A.T.I<. and R.M. Nakamura: Newer Concepts in the Patho-
physiology of Experimental Dysbarism-Decompression Sickness.
Amer. Surg. 30:447, 1964.
Cockett, A.T.K., R.M. Nakamura and R:T. Kado: Physiological
Factors in Decompression Siclness. Arch. Environ., Health
11:760, 1965.
Cockett, A.LK., R.M. Nakamura and J.J. Franks: Recent Findinas
In the • Pathogenesis of Decompression Sicknoss (Dysbarism). Surgery
58 :384,; 1965.
CDckedi A.T.K., N.L. Mangelson, L. Swanson an'tl R.T. Kado: The
Diagnosis of Experimental Pulmonary Aeroemboli Following Dacompi:ession
by Radioisotopic Long Scanning. Amar. Surg. 34:109, 1960.
Philp, R.Q., Govedey, C.W.. and M. Prosall: (Ionaes in Blood Lipid
Concentration and Coll Counts Following Decompression Sickness in
Rats and the Influence of Diatary Lipid. Can. a. Physiol. Pharm.
45:1047, 1967.
^i.	 Parthelerny, L.: Blood Cougulution and Chemistry Dm ing Experimental
Divos and the Trectirsient of Diving Accidents with 1-iopurin. Second
Sympsitica on Undcrwater Physiolojy, - \Mash. V.C., Nat. Acrid. Sci.
Pub. 118146, 19,63.
90	 Cocicoii; A.T.I:., J.C. Snunc!crs and S.M. Pauley: Troaimcnt of
`
	
	
Cxperim:ntal Decompression Sickness by I-lepurin Alone. Presenled at
Annual Aliectincg of Aerospaco Med. Assoc., May 7, 1968, San Francisco,
Californ.m.
Y
